Relmada Therapeutics is a clinical-stage pharmaceutical company that develops treatments for aggressive bladder cancer and various neurological disorders. Its primary focus is on advancing chemical formulations through human medical trials to address conditions like Tourette syndrome and excessive tremors. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
